Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T6916 |
OICR-9429
OICR 9429 |
Histone Methyltransferase; JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
OICR-9429 是一个新颖的相互作用的小分子Wdr5-MLL 拮抗剂,IC50是 5 uM,在体外抑制急性髓性白血病细胞。 | |||
T8768 |
MM-102 TFA
HMTase Inhibitor IX TFA |
Histone Methyltransferase | Chromatin/Epigenetic |
MM-102 TFA (HMTase Inhibitor IX TFA) 是一种有效的 WDR5/MLL 相互作用抑制剂,在 WDR5 结合检测中,IC50为 2.4 nM,Ki 小于 1 nM。 | |||
T13334 | WDR5-IN-1 | Others | Others |
WDR5-IN-1 is a potent and selective inhibitor of WD repeat domain 5 (WDR5) (Kd <0.02 nM), and also inhibits MLL1 histone methyltransferase (HMT) activity (IC50: 2.2 nM). | |||
T12091 |
MM-589
|
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
MM-589 is a potent WD repeat domain 5 (WDR5) inhibitor and mixed lineage leukemia (MLL) protein-protein interaction. | |||
T12091L |
MM-589 TFA
|
JAK | Angiogenesis; Chromatin/Epigenetic; JAK/STAT signaling; Stem Cells |
MM-589 TFA is a potent WD repeat domain 5 (WDR5)inhibitor and mixed lineage leukemia (MLL) protein-protein interaction. | |||
T63763 | WDR5-IN-5 | ||
WDR5-IN-5 是选择性的、口服具有活力的、靶向 WD 重复结构域 5 (WDR5)WIN 位点的抑制剂。WDR5-IN-5 对 WDR5 表现出高亲和力 (Ki<0.02 nM)。WDR5-IN-5 表现出抗癌细胞增殖作用以及良好的药代动力学特征。 |